Stage 4 Breast Cancer Survivor's Decade-Long Fight

Lynette McHendry has spent the last ten years battling an aggressive form of breast cancer, a journey marked by resilience and a determined fight for accessible treatment. Diagnosed at age 37, her stage four diagnosis, which once seemed like a 'death sentence,' has been met with advancements in medical therapies, offering a more positive outlook for many.

Her personal experience underscored significant disparities in cancer care, particularly the lack of access to specific treatments in Northern Ireland. This led her to seek second opinions and specialized care in London, where genetic testing confirmed her BRCA1 positivity, paving the way for platinum chemotherapy and PARP inhibitors.

This advocacy, alongside fellow patients, contributed to a crucial audit on stage four breast cancer in Northern Ireland, influencing policy and services. Professor Stuart McIntosh of Queen's University Belfast notes substantial improvements, crediting pioneering national clinical trials and targeted drugs now more available locally.

Despite secondary diagnoses, including brain cancer requiring craniotomies, Lynette achieved No Evidence of Active Disease (NEAD) in 2018 and maintains remission. She now advocates for patient education and shared knowledge, emphasizing that living with cancer is possible with better treatments and increased awareness.